Ocugen Files DEFA14A Proxy Materials
Ticker: OCGN · Form: DEFA14A · Filed: Apr 28, 2026 · CIK: 0001372299
| Field | Detail |
|---|---|
| Company | Ocugen, Inc. (OCGN) |
| Form Type | DEFA14A |
| Filed Date | Apr 28, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, regulatory, shareholder-communication
Related Tickers: OCGN
TL;DR
OCGN filed proxy docs 4/28/26 - shareholders need to pay attention.
AI Summary
Ocugen, Inc. filed a DEFA14A on April 28, 2026, related to additional definitive proxy soliciting materials. The filing, with SEC Accession No. 0001140361-26-017263, includes various documents such as the main DEFA14A filing and graphic files. The company's principal executive offices are located at 11 Great Valley Parkway, Malvern, PA 19355.
Why It Matters
This filing indicates important corporate actions or shareholder communications are being made by Ocugen, Inc., requiring shareholder attention and potential voting.
Risk Assessment
Risk Level: low — A DEFA14A filing is a standard regulatory document for proxy solicitations and does not inherently represent a change in the company's financial or operational risk.
Key Numbers
- 0001140361-26-017263 — SEC Accession Number (Unique identifier for the filing)
- 2026-04-28 — Filing Date (Date the document was officially filed)
Key Players & Entities
- Ocugen, Inc. (company) — Filer
- 0001140361-26-017263 (dollar_amount) — SEC Accession Number
- 2026-04-28 (dollar_amount) — Filing Date
- 11 Great Valley Parkway Malvern PA 19355 (company) — Mailing and Business Address
FAQ
What is the primary purpose of a DEFA14A filing?
A DEFA14A filing is used for additional definitive proxy soliciting materials and Rule 14(a)(12) material, typically related to shareholder meetings and voting.
What is the SEC Accession Number for this Ocugen filing?
The SEC Accession Number for this filing is 0001140361-26-017263.
When was this DEFA14A filing accepted by the SEC?
This filing was accepted on 2026-04-28 at 07:01:37.
Where are Ocugen, Inc.'s principal executive offices located?
Ocugen, Inc.'s principal executive offices are located at 11 Great Valley Parkway, Malvern, PA 19355.
What type of company is Ocugen, Inc. based on its SIC code?
Ocugen, Inc. is classified under SIC code 2836, which pertains to Biological Products (No Diagnostic Substances).
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 28, 2026 regarding Ocugen, Inc. (OCGN).